Adaptive Biotechnologies vs Lexeo Therapeutics
Adaptive Biotechnologies vs Lexeo Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Lexeo Therapeutics on 61/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 61/100
- domain rating: 61/100 against 41/100
Lexeo Therapeutics
- funding raised: $495M against $300M
At a glance
| Measure | Adaptive Biotechnologies | Lexeo Therapeutics |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Platform |
| Founded | 2009 | 2020 |
| Headquarters | Seattle, United States | New York City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Lexeo Therapeutics |
|---|---|---|
| Employees | Not published | 91 |
| Total funding | $300M | $495M |
| Latest round | Series D | Public Offering |
| LinkedIn followers | Not published | 16,654 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Lexeo Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 61/100 |
| Traction | Not published | 60/100 |
| Team | Not published | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | Not published | 28/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 41/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Lexeo Therapeutics |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
Adaptive Biotechnologies vs Lexeo Therapeutics: common questions
Which is better, Adaptive Biotechnologies or Lexeo Therapeutics?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 61/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Lexeo Therapeutics compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 61/100), domain rating (61/100 against 41/100). Lexeo Therapeutics leads on funding raised ($495M against $300M).
Read the full Adaptive Biotechnologies review and pricing or the Lexeo Therapeutics review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.